Kaléo

Dave Bloom - 2017/07/05

One example of the changing market dynamics for epinephrine auto-injectors in light of recent developments.

Dave Bloom - 2017/06/16

The additional competition should help lower costs across the emergency epinephrine market.

Dave Bloom - 2017/06/02

Arcane system of pricing and insurance rebates at heart of the suit.

Dave Bloom - 2017/04/25

More legal troubles for the embattled marketer of EpiPen.

Dave Bloom - 2017/04/25

May cost as low as $0 to consumers with commercial health insurance.

Dave Bloom - 2017/02/13

Pricing for their Evzio naloxone auto-injector is similar to that of their recently relaunched Auvi-Q epinephrine auto-injector.

Dave Bloom - 2017/02/10

Innovation and participation by insurers will be key to the successful reintroduction of the device.

Dave Bloom - 2017/01/25

Will kaleó succeed in providing an affordable auto-injector alternative to families in desperate need?

Dave Bloom - 2017/01/19

The company pledges $0 out-of-pocket expenses for many when the auto-injector is reintroduced February 14. FAQ included in article.

Dave Bloom - 2016/11/29

We discuss the changes kaléo is making to the manufacture and quality assurance of Auvi-Q prior to its reintroduction in 2017.

Tag: Kaléo